In today’s episode, Dr. Seema Aggarwal sat down with Dr. Yejin Kim to discuss Dr. Kim, along with many other UTHealth Houston and Stroke Institute researchers, an article from March 2022, a counterfactual analysis of differential comorbidity risk factors in Alzheimer’s disease and related dementias. Their analysis discovered different comorbidities that predispose older African Americans to AD compared to Caucasian counterparts. The findings from their study, which used data collected from nationwide electronic health records will assist in developing a targeted treatment for AD. Their discussion also provided great insight into the processes Kim and her team went through to complete their study and their hopes for applications in the future.
__________
The Institute for Stroke and Cerebrovascular Disease (UTHealth Stroke Institute) http://www.utstrokeinstitute.com/
Guest: Yejin Kim, PhD
Twitter: @UTHealthStroke
Instagram: @UTHealthStroke
Facebook: facebook.com/uthealthstroke
Ideas and opinions are our own and this podcast is not a substitute for expert medical advice.
About
StrokeBusters is a podcast series of recorded conversations on the topic of stroke and cerebrovascular disease. Based in the Texas Medical Center, the largest medical center in the world, we tap into our local network of astonishing leaders in healthcare and medicine to discuss the latest and most exciting news on stroke. Throughout this ten-episode series, we connect with UTHealth physicians and researchers, many of who are experts in their field, to discuss their practice, cutting-edge research, and medical care.
Who We Are
The Institute for Stroke and Cerebrovascular Disease, better known as the Stroke Institute, serves as a multi-disciplinary hub for research and best practices in stroke recovery, stroke prevention, services, population health, and vascular dementia. We are one of the most active research and clinical programs in the country, the first Comprehensive Stroke Center in the state, and launched the first Mobile Stroke Unit in the nation.
Our stroke program, founded by Dr. James Grotta in 1979, specializes in stroke epidemiology, clinical trial design, and basic science. We train the next generation of revolutionary academics and leaders in cerebrovascular disease through our NINDS-funded fellowship programs.
Contact
For more information or if you have any questions, please contact us at info.uthiscd@gmail.com
